A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Under the direction of Donna Farber, PhD, the recently revitalized Division of Surgical Sciences aims to foster basic science research and train a new generation of scientists.
Two research teams at Columbia University Irving Medical Center have received grants from the Chan Zuckerberg Initiative to help build a Human Cell Atlas.
Joachim Frank discusses the call from Sweden and his work using cryo-electron microscopy to reveal the three-dimensional shapes of biological molecules.
Jeffrey Hall, Michael Rosbash, and Michael Young were awarded the 2017 Nobel Prize in Physiology or Medicine for their discoveries of molecular mechanisms controlling circadian rhythm.
Macrophages can eat up to 70 dead cells a day, preventing atherosclerosis. A new CUIMC study finds that mitochondria play a critical role in the process.
Columbia University Irving Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action.
Postdoctoral fellow Ewoud Schmidt and graduate student Ori Lieberman received the 2017 Regeneron Prize for Creative Innovation, an award recognizing early-career biomedical scientists.